IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $7,565,000 | -93.5% | 88,966 | -97.3% | 0.02% | -94.1% |
Q2 2020 | $117,177,000 | +1384.8% | 3,306,343 | +497.8% | 0.41% | +1313.8% |
Q4 2018 | $7,892,000 | -66.1% | 553,055 | -50.5% | 0.03% | -55.4% |
Q3 2018 | $23,278,000 | -31.8% | 1,117,518 | -22.4% | 0.06% | -35.0% |
Q2 2018 | $34,108,000 | +149.6% | 1,440,959 | +54.1% | 0.10% | +143.9% |
Q1 2018 | $13,665,000 | -9.8% | 935,328 | -0.3% | 0.04% | -4.7% |
Q4 2017 | $15,156,000 | -4.2% | 937,890 | -17.1% | 0.04% | -6.5% |
Q3 2017 | $15,815,000 | +49.6% | 1,131,284 | -5.5% | 0.05% | +48.4% |
Q2 2017 | $10,570,000 | – | 1,197,083 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |